GeneInsight Acquisition Boosts Sunquest's Clinical Genetics IT Platform | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

GeneInsight Acquisition Boosts Sunquest's Clinical Genetics IT Platform

April 4, 2016
by David Raths
| Reprints
Developed at Partners Healthcare, GeneInsight helps integrate genetics into routine diagnostic workflows

Laboratory information systems vendor Sunquest Information Systems Inc. has acquired GeneInsight Inc., a company that streamlines the analysis, interpretation and reporting of complex genetic tests.

Sunquest's investment in GeneInsight supports its efforts to integrate genetics into routine diagnostic workflows and make findings available to clinicians in real-time.

The GeneInsight platform was developed by Partners HealthCare in Boston and has been in clinical use since 2005 at the Laboratory for Molecular Medicine. In 2014, Sunquest made an investment in GeneInsight and established an alliance with Partners to accelerate genomic-based medicine. Since that time, Tucscon, Ariz.-based Sunquest and Partners have collaborated to provide seamless genetic testing workflow capabilities to geneticists and pathologists alike.

Under the terms of the agreement, GeneInsight will become a wholly owned subsidiary of Sunquest and maintain its existing Boston-based office.

Sunquest said it would provide integration capabilities with other healthcare IT vendors including EHRs, LIMS and genetic content providers. The company will also continue to further develop VariantWire, a networking infrastructure and crowd-sourcing platform designed to enable high-throughput transfer of structured genetic data between and among laboratories and clinicians.

"GeneInsight's goal is to provide clinicians and laboratories with the ability to constantly improve clinical genetic processes and enable deeper cross-organizational communication for the benefit of patients," said Sandy Aronson, executive director of information technology, Partners HealthCare's Personalized Medicine and a founder of GeneInsight, in a prepared statement. "Sunquest will bring the GeneInsight solution to far more institutions, furthering its integration into pathology workflows and, by doing so, enable it to help many more people."

In 2015, Sunquest’s parent company, Roper Technologies Inc. (NYSE: ROP), acquired both CliniSys Group Ltd., one of the largest European suppliers of laboratory information management systems (LIMS), and Atlas Medical, a provider of clinical process and connectivity solutions.

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


See more on

betebet sohbet hattı betebet bahis siteleringsbahis